| Document And Entity Information | May 11, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | May 11, 2024 |
| Entity Registrant Name | Fulcrum Therapeutics, Inc. |
| Entity Central Index Key | 0001680581 |
| Entity Emerging Growth Company | true |
| Entity File Number | 001-38978 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 47-4839948 |
| Entity Address, Address Line One | 26 Landsdowne Street |
| Entity Address, City or Town | Cambridge |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02139 |
| City Area Code | (617) |
| Local Phone Number | 651-8851 |
| Entity Information, Former Legal or Registered Name | N/A |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Ex Transition Period | false |
| Title of 12(b) Security | Common stock, par value $0.001 per share |
| Trading Symbol | FULC |
| Security Exchange Name | NASDAQ |
